How effective is immunotherapy for lymphoma?

Lymphoma is a group of different cancers of immune-system cells. Immunotherapy may use antibodies that attach to a marker on lymphoma cells, medicines that release immune brakes, or engineered immune cells that target the cancer. The option depends on the exact subtype, marker testing, whether the disease is newly diagnosed or has returned, and treatments already received.

Doctors follow blood tests, examinations and imaging to see whether lymph nodes or other affected areas are responding. With some immune-based treatments, symptoms can improve before every scan changes. The team also watches blood counts and organ function because treatment can alter immune activity or make infections harder to handle.

Confirm the pathology diagnosis and ask whether marker testing is needed. Give the team a complete record of chemotherapy, radiotherapy, transplant procedures, infections, vaccinations and medicines. Before treatment, ask about infusion reactions, infection precautions, fertility, travel and the practical support needed at home. During therapy, record fever, new pain, bowel changes, rash, confusion or unusual weakness and share these changes promptly.

Seek emergency care for difficulty breathing, facial swelling, collapse, severe confusion, a seizure, uncontrolled bleeding or a very high fever. Contact the lymphoma team urgently for chills, persistent fever, severe diarrhoea, a spreading rash, new neurological symptoms or sudden weakness. People receiving immune-altering treatment may need rapid tests and treatment for infection, inflammation or an infusion reaction.

Which lymphoma subtype and marker results guide my treatment? Is this immunotherapy intended as initial treatment, consolidation or treatment after relapse? How will you judge response? What infection risks should I plan for? Which symptoms during or after an infusion need immediate attention, and whom should I call outside clinic hours?